
CymaBay Therapeutics has announced positive topline results from its phase 3 RESPONSE study which assessed the safety and efficacy of …
PCTs have received a mixed report from practice-based commissioners, less than a third of who rate the quality of PCT …
Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

